Metabolic Inhibitor holds Promise as Preventative for Covid-

Work to develop a new formulation of a common metabolic inhibitor (niclosamide) by David Needham, Professor of Translational Therapeutics in the School of Pharmacy at the University of Nottingham and Professor of Mechanical Engineering and Materials Science at Duke University, could result in a promising early treatment for Covid-19. Click to read more...

Related Keywords

North Carolina , United States , Nottingham , United Kingdom , Duke University , Christina Barkauskas , David Needham , Duke Durham , University Of Nottingham , School Of Pharmacy , Materials Science At Duke University , Translational Therapeutics , Mechanical Engineering , Materials Science , Professor Needham , Patty Lee , Spray , Virus , Nasal , Niclosamide , Cells , Formulation , Early , Treatment , Covid , Studies ,